Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

MEDICAL PPTYS   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2024202320222021202020192018201720162015
Period End Date12/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/2015
Straight-line rent163.41(127.89)204.16241.43158.88110.4674.7465.4741.0723.38
Rent billed719.75803.38968.87931.94741.31474.15473.34435.78327.27247.60
Income from direct financing leases63.65127.14203.58202.60206.55119.6273.9874.5064.3158.72
Interest and fee income48.7369.18166.24168.70142.50149.97162.46129.00108.49112.18
Total Revenues995.55871.801,542.851,544.671,249.24854.20784.52704.75541.14441.88
Property-related27.2641.5745.7039.1024.8923.999.245.812.713.79
Real estate depreciation and amortization447.66603.36332.98321.25264.25152.31133.08125.1194.3769.87
General and administrative133.79145.59160.49145.64131.6696.4180.0958.6048.9143.64
Acquisition expenses----------0.000.9229.6546.2761.34
Impairment charge----------(21.03)(48.01)0.00(7.23)0.00
Loan impairment charge--------------------
Interest(417.82)(411.17)(359.04)(367.39)(328.73)(237.83)(223.27)------
Total operating expenses1,026.531,201.69898.20873.38749.53510.55446.60219.16199.50178.64
Operating Income (Loss)--------------485.58341.64263.24
Interest expense--------------176.95159.60120.88
Real estate impairment charges1,825.40376.91268.38--19.01----------
Gain on sale of real estate and other asset dispositions, net478.69(1.82)536.7652.47(2.83)41.56719.397.4361.22--
Earnings from equity and other interests(366.64)13.9740.8028.4920.4216.05--10.06(1.12)2.85
Interest income------------------0.60
Other income (expense)(615.57)7.5915.346.29(6.78)(0.35)10.090.37(0.50)--
Debt refinancing costs(4.29)0.29(9.45)(27.65)(28.18)(6.11)0.00(32.57)(22.54)(4.37)
Net Non Operating Expenses(2,333.21)(356.88)315.0759.60(36.38)30.13681.48(194.35)(115.70)(123.31)
Pre-Tax Income(2,364.19)(686.77)959.72730.89463.33373.781,019.40293.92--141.43
Income tax expense (benefit)44.10(130.68)55.9073.9531.06(2.62)0.932.68(6.83)1.50
Current - Domestic0.48(7.76)(1.11)1.56(0.06)(0.06)(0.13)------
Current - Foreign(31.59)(24.26)27.7518.9610.201.673.29------
Deferred - Domestic(0.47)8.9315.63(6.92)10.68(5.49)(3.71)------
Deferred - Foreign(12.52)153.7713.6360.3410.241.261.47------
Minority interests in consolidated partnerships--------------------
Income from continuing operations--------------291.24225.94139.93
Income from discontinued operations--------------0.000.000.00
Consolidated net income (loss)(2,408.29)(556.09)903.82656.94432.27376.401,018.48291.24225.94139.93
Net income attributable to non-controlling interests1.980.381.220.920.821.721.791.450.890.33
Net income (loss) available to common shareholders(2,410.27)(556.48)902.60656.02431.45374.681,016.69289.79225.05139.60
Income from continuing operations--------------0.820.860.64
Income from discontinued operations------------------0.00
Net Earnings Per Share (Basic)(4.02)(0.93)1.501.110.810.872.770.820.860.64
Income from continuing operations--------------0.820.860.63
Income from discontinued operations------------------0.00
Net Earnings Per Share (Diluted)(4.02)(0.93)1.501.110.810.872.760.820.860.63
Weighted Average Shares Outstanding (Basic)600.25598.52598.63588.82529.24427.08365.36349.90260.41218.00
Weighted Average Shares Outstanding (Diluted)600.25598.52598.84590.14530.46428.30366.27350.44261.07218.30
Funds From Operations (FFO)(1,400.12)287.79934.31975.99757.68535.77485.34408.51253.48205.17